CervoMed Inc. (CRVO)
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.
$2.50-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-71.7%
The outlook
CervoMed Inc. currently reads as leaning bearish based on below its 50- & 200-day averages, 4% of the way from its 52-week low to high, avg target +680% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Price targetAvg target +680% vs current price
Analyst price target
~12-month · 6 analysts$19.50average target+680.0% vs now
Now $2.50
Low $9.00High $27.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$23.1M
52-wk high
$11.25
52-wk low
$2.13
50-day avg
$3.13
200-day avg
$5.24
Trailing P/E
—